Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian N Fleming

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine Communications|February 28, 2012
Positron emission tomography oncology research in the UK: a comparison with USA and EuropeIan N Fleming, Sabine J Regel, Lucy C Pike, et al.
Organic & Biomolecular Chemistry|June 5, 2013
Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of α(v)β(3) integrin receptorSergio Dall'Angelo, Qingzhi Zhang, Ian N Fleming, et al.
Nuclear Medicine Communications|July 10, 2012
Positron emission tomography radiopharmaceutical studies in humans: a guide to regulations for academic researchersIan N Fleming, Mark Whelan, Roy Baxendale, et al.
Bioconjugate Chemistry|April 15, 2016
NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) TargetingAlessandra Graziadio, Matteo Zanda, Simona Frau, et al.
The Biochemical Journal|November 8, 2003
Detection of novel intracellular agonist responsive pools of phosphatidylinositol 3,4-bisphosphate using the TAPP1 pleckstrin homology domain in immunoelectron microscopyStephen A Watt, Wendy A Kimber, Ian N Fleming, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2012
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoestersTim A D Smith, M Virginia C L Appleyard, Sheila Sharp, et al.
The Biochemical Journal|July 10, 2004
Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1Ian N Fleming, Ian H Batty, Alan R Prescott, et al.
Chemmedchem|June 14, 2017
High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging α<sub>v</sub> β<sub>3</sub> IntegrinMonica Piras, Andrea Testa, Ian N Fleming, et al.
European Radiology|April 6, 2012
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trialsEric O Aboagye, Fiona J Gilbert, Ian N Fleming, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine Communications|February 28, 2012
Positron emission tomography oncology research in the UK: a comparison with USA and EuropeIan N Fleming, Sabine J Regel, Lucy C Pike, et al.
Organic & Biomolecular Chemistry|June 5, 2013
Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of α(v)β(3) integrin receptorSergio Dall'Angelo, Qingzhi Zhang, Ian N Fleming, et al.
Nuclear Medicine Communications|July 10, 2012
Positron emission tomography radiopharmaceutical studies in humans: a guide to regulations for academic researchersIan N Fleming, Mark Whelan, Roy Baxendale, et al.
Bioconjugate Chemistry|April 15, 2016
NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) TargetingAlessandra Graziadio, Matteo Zanda, Simona Frau, et al.
The Biochemical Journal|November 8, 2003
Detection of novel intracellular agonist responsive pools of phosphatidylinositol 3,4-bisphosphate using the TAPP1 pleckstrin homology domain in immunoelectron microscopyStephen A Watt, Wendy A Kimber, Ian N Fleming, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2012
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoestersTim A D Smith, M Virginia C L Appleyard, Sheila Sharp, et al.
The Biochemical Journal|July 10, 2004
Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1Ian N Fleming, Ian H Batty, Alan R Prescott, et al.
Chemmedchem|June 14, 2017
High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging α<sub>v</sub> β<sub>3</sub> IntegrinMonica Piras, Andrea Testa, Ian N Fleming, et al.
European Radiology|April 6, 2012
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trialsEric O Aboagye, Fiona J Gilbert, Ian N Fleming, et al.
Pageof 3